Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
Intensity Therapeutics has raised $4.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Intensity Therapeutics's investors include VCapital, Jim Mellon, Declan Doogan, Batterson Venture Capital, SalvaRx Group PLC.
Intensity Therapeutics is headquartered in Norwalk, United States.
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
Intensity Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intensity Therapeutics — Funding & Investors." VCBacked, October 31, 2025, https://www.vcbacked.co/company/intensity-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Intensity Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/intensity-therapeutics
{{cite web |title=Intensity Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intensity-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated